Dedicated investigators and clinicians bring expertise in drug development and flexible study design
Timing of adjuvant immunotherapy unclear for maximum overall survival
Notable research chosen by Cleveland Clinic Cancer Center staff
Immune therapy and targeted therapies have led to durable responses and potential cures
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Study finds high levels of a CD8 T-cell subpopulation to be predictive of ICI resistance
A brief look at our programs
Overall survival benefit not established
35-year-old presents with suspected iris melanoma
Cutaneous complications common post-transplant
Cutaneous complications common post-transplant